Skip Navigation

JNCI Journal of the National Cancer Institute 2005 97(17):1247; doi:10.1093/jnci/dji300
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Hayasaka, E.
Right arrow Articles by Zielinski, S. L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hayasaka, E.
Right arrow Articles by Zielinski, S. L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 Oxford University Press

NEWS

In Brief

Elana Hayasaka, Sarah L. Zielinski

The first 10% of the full text of this article appears below.

Drug Companies Adopt New Advertising Guidelines

A group representing much of the U.S. pharmaceutical industry has announced a new set of voluntary guidelines for direct-to-consumer advertising of prescription drugs.

The Pharmaceutical Research and Manufacturers of America (PhRMA) approved the guiding principles on July 29, and they will go into effect January . . . [Full Text of this Article]

Anastrozole After Tamoxifen May Benefit Women With Early Breast Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?